Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-Iminobiotin added to therapeutic hypothermia in neonates with perinatal asphyxia
NL-OMON20368Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 2-iminobiotin in hypoxic-ischemic encephalopathy (HIE) and asphyxia neonatorum, sponsored by University Medical Center Utrecht. Primary endpoints: Short-term safety and tolerability and Pharmacokinetics of 2-iminobiotin. Started Jun 2015; status: active, not recruiting.
02
Drugs
2-iminobiotin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)asphyxia neonatorum
Beyond the preview
Go deeper on NL-OMON20368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20368.